Jill H. Hardin, MBA, MS, PhD

Director
Global Epidemiology, Johnson & Johnson

Poster(s):

• (C-241) A Retrospective Cohort Study of Sarcopenia in Patients with Type 2 Diabetes Mellitus treated with SGLT2 Inhibitors and Other Antihyperglycemic Agents
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-202) Active Safety Surveillance Using Real-world Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence (RWE) Standardized Framework to Support Safety Signal Evaluation
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-217) Incidence of Cataract Among Patients Exposed to FGFR Inhibitors in the Real-World
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET